Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Kieseier

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Nature Reviews. Neurology|January 30, 2013
Multiple sclerosis: reprogramming the immune repertoire with alemtuzumab in MSHeinz Wiendl, Bernd Kieseier
JAMA Neurology|September 10, 2014
Relevance of CD34+ cells as a reservoir for JC virus in patients with multiple sclerosisClemens Warnke, Ortwin Adams, Bernd Kieseier
Trends in Neurosciences|January 5, 2010
Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosisOrhan Aktas, Bernd Kieseier, Hans-Peter Hartung
Current Neurology and Neuroscience Reports|April 15, 2003
New immunopathologic insights into multiple sclerosisBernhard Hemmer, Bernd Kieseier, Sabine Cepok, et al.
Nature Reviews. Neurology|June 17, 2010
Fingolimod is a potential novel therapy for multiple sclerosisOrhan Aktas, Patrick Küry, Bernd Kieseier, et al.
Nature Clinical Practice. Neurology|August 26, 2006
Immunopathogenesis and immunotherapy of multiple sclerosisBernhard Hemmer, Stefan Nessler, Dun Zhou, et al.
The Lancet. Neurology|June 21, 2005
Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosisBernhard Hemmer, Olaf Stüve, Bernd Kieseier, et al.
Journal of Neurology|November 16, 2007
Multiple sclerosis therapy: an update on recently finished trialsChristoph Kleinschnitz, Sven G Meuth, Olaf Stüve, et al.
Journal of Neurology|November 19, 2009
Development of oral cladribine for the treatment of multiple sclerosisHans-Peter Hartung, Orhan Aktas, Bernd Kieseier, et al.
Blood|February 1, 2008
The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humansFabian Zohren, Diamandis Toutzaris, Viola Klärner, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Nature Reviews. Neurology|January 30, 2013
Multiple sclerosis: reprogramming the immune repertoire with alemtuzumab in MSHeinz Wiendl, Bernd Kieseier
JAMA Neurology|September 10, 2014
Relevance of CD34+ cells as a reservoir for JC virus in patients with multiple sclerosisClemens Warnke, Ortwin Adams, Bernd Kieseier
Trends in Neurosciences|January 5, 2010
Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosisOrhan Aktas, Bernd Kieseier, Hans-Peter Hartung
Current Neurology and Neuroscience Reports|April 15, 2003
New immunopathologic insights into multiple sclerosisBernhard Hemmer, Bernd Kieseier, Sabine Cepok, et al.
Nature Reviews. Neurology|June 17, 2010
Fingolimod is a potential novel therapy for multiple sclerosisOrhan Aktas, Patrick Küry, Bernd Kieseier, et al.
Nature Clinical Practice. Neurology|August 26, 2006
Immunopathogenesis and immunotherapy of multiple sclerosisBernhard Hemmer, Stefan Nessler, Dun Zhou, et al.
The Lancet. Neurology|June 21, 2005
Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosisBernhard Hemmer, Olaf Stüve, Bernd Kieseier, et al.
Journal of Neurology|November 16, 2007
Multiple sclerosis therapy: an update on recently finished trialsChristoph Kleinschnitz, Sven G Meuth, Olaf Stüve, et al.
Journal of Neurology|November 19, 2009
Development of oral cladribine for the treatment of multiple sclerosisHans-Peter Hartung, Orhan Aktas, Bernd Kieseier, et al.
Blood|February 1, 2008
The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humansFabian Zohren, Diamandis Toutzaris, Viola Klärner, et al.
Pageof 3